Zostavax was approved by the FDA to prevent shingles in individuals 50 years of age and older
On Mar. 24, 2011, Zostavax, manufactured by Merck of Whitehouse Station, New Jersey, was approved by the U.S….
-
-
Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
On Feb. 22, 2011, Foster City, California-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
-
FDA approved Gardasil HPV vaccine to include the indication for the prevention of anal cancer
On Dec. 22, 2010, the FDA approved Gardasil HPV vaccine to include the indication for the prevention of…
-
Biotechnology | FDA | Oncology | Therapeutics
PROVENGE was approved by the FDA
On Apr. 29, 2010, the FDA approved sipuleucel-T (PROVENGE), made by the Dendreon, an autologous cellular immunotherapy for…
-
FDA recommended physicians suspend use of GSK’s Rotarix rotavirus vaccine due to porcine circovirus 1 contamination
On Mar. 22, 2010, the U.S. Food and Drug Administration (FDA) recommended that physicians temporarily suspend use of…
-
FDA approved licensure of Pneumococcal 13-valent conjugate vaccine
On Feb. 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, a subsidiary of Pfizer])…
-
FDA approved licensure of Menveo (Novartis), meningococcal conjugate vaccine
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
-
FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis
On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…
-
FDA approved Cervarix, GlaxoSmithKline’s cervical cancer vaccine
On Oct. 16, 2009, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Cervarix [Human papillomavirus…
-
FDA approved new indication for gardasil to prevent genital warts in men and boys
On Oct. 16, 2009, the U.S. Food and Drug Administration (FDA) approved new indication for gardasil to prevent…
-
FDA approved four vaccines against the 2009 H1N1 influenza virus
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
-
Vaccine Court ruled that MMR vaccine does not cause autism
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
-
FDA approved first genetically engineered animal for production of a recombinant form of human antithrombin
On Feb. 12, 2009, The US Food and Drug Administration issued its first approval for a biological product produced…
-
FDA approved changes in the schedule for administering anthrax vaccine
On Dec. 19, 2008, the Food and Drug Administration (FDA) approved changes in the schedule for administering anthrax…
-
FDA approved expanded indication for use of Boostrix Tdap vaccine in people ages 10-64 years
On Dec. 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus…
-
The U.S. FDA opened its first foreign office in Beijing
On Nov. 19, 2008, the U.S. Food and Drug Administration opened its first foreign office in Beijing to…
-
Biotechnology | FDA | Polio | Vaccine
FDA approved new DTaP-IPV vaccine (Kinrix) for use in children ages 4-6 years
On Jun. 24, 2008, GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) had approved KINRIX™ [Diphtheria…
-
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
-
FDA approved Pentacel, a new combination DTaP-IPV-Hib vaccine for use in children 6 weeks-34 yrs of age
On Jun. 20, 2008, the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Vaccine
CDC announced it had begun distribution of a new-generation smallpox vaccine
On Feb. 29, 2008, the U.S. Centers for Disease Control and Prevention (CDC) announced it had begun distribution…
-
Biotechnology | Disease | FDA | Therapeutics
ZymoGenetics received FDA authorization to manufacture the product Thrombin topical (Recombinant)
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…
-
FDA Approved Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
On Jan. 8, 2008, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) had approved Cialis(R)…
-
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
-
Biotechnology | FDA | NIH | Pharmaceutical
The FDA Amendments Act of 2007 reauthorized collection of prescription drug user fees
On Sept. 27, 2007, President George W. Bush signed into law H.R. 3580, the Food and Drug Administration…
-
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
-
OHSU became the first in Oregon to offer a new artificial disk for the neck
On Aug. 16, 2007, surgeons at Oregon Health and Science University announced implanting a new artificial disc in…
-
FDA approved the H5N1 vaccine, the first vaccine approved for avian flu
On Apr. 17, 2007, Sanofi announced that the U.S. Food and Drug Administration (FDA) had licensed its H5N1…
-
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the U.S. Food and Drug Administration (FDA) announced that GlaxoSmithKline (King of Prussia, Pennsylvania)…
-
Eli Lilly completed its acquisition of ICOS Corp for $23 billion
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
